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Maxillomandibularadvancement(MMA)isasurgicaloptionforobstructivesleepapnea(OSA).MMAinvolvesforward-ﬁxingthe
maxilla and mandible approximately 10 mm via Le Fort I maxillary and sagittal split mandibular osteotomies. We retrospectively
reviewedoutcomesfrom24consecutiveOSApatientswhounderwentMMAatourinstitution.MMAresultedinan83%reduction
in the group mean apnea-hypopnea index (AHI) per polysomnography an average of 6.7 months after surgery. Forty-two percent
of patients achieved a post-MMA AHI of less than 5 events/hour sleep and 71% achieved an AHI less than or equal to 10
events/hour sleep. The Epworth Sleepiness Scale score decreased by an average of 5 post-surgery. No parameters predictive of
cure for OSA by MMA were identiﬁed.
1.Introduction
Obstructive sleep apnea (OSA) is a common disorder [1]
associated with signiﬁcant morbidity and mortality [2, 3].
Critical narrowing of the upper airway during sleep occurs
behind the uvula and soft palate, at the base of the tongue,
or at both sites and develops due to a dysfunctional interplay
of anatomic factors narrowing the airway and compensatory
neuromuscular mechanisms insuﬃcient to maintain airway
patency [4]. Continuous positive airway pressure (CPAP),
which pneumatically splints the upper airway, is considered
the therapeutic mainstay for OSA [5] yet a signiﬁcant
minority of patients struggle to adhere to this therapy [6].
Greater than 50% of patients experience CPAP-associated
side eﬀects that may be related to the prescribed pressure,
interface, and/or equipment [7]. Accordingly, physicians
may consider non-CPAP treatment alternatives for their
OSA patients, including risk factor modiﬁcations [8], oral
appliances [9], or a variety of surgical procedures performed
singularly, sequentially, or simultaneously [10].
The role of upper airway surgery for OSA has been
contentious [11, 12]. Most upper airway surgeries for OSA
have limited success if stringent criteria are applied with
respect to the apnea-hypopnea index (AHI), the traditional
disease-deﬁning statistic for OSA [13]. Uvulopalatopharyn-
goplasty (UPPP), perhaps the most common surgery
performed for OSA, results in normalization of the AHI in
less than 20% of patients [13]. Similarly, procedures such as
nasal reconstruction, laser-assisted uvulopalatoplasty, hyoid
suspension, and radiofrequency ablation of upper airway
structures are generally not curative options for OSA [10].
A surgical procedure with an apparently greater eﬃcacy
for lowering the AHI is maxillomandibular advancement
(MMA) which enlarges the upper airway and decreases
upperairwaycollapsibility[14]byforward-ﬁxingthemaxilla
and mandible approximately 10mm via Le Fort I maxillary
and sagittal split mandibular osteotomies [15]. The potential
advantages of MMA include a single-stage surgery to address
retropalatal and retrolingual obstruction and preservation of
pharyngeal tissue functional integrity [16]. Though edema
and hypopharyngeal hematoma may occur in the immediate
postoperative period following MMA, there appears to be
a minimal risk for airway compromise or postoperative
exacerbation of OSA [17]. Indeed, CPAP-like reductions in2 International Journal of Otolaryngology
the AHI of nearly 90% with MMA have been reported [16,
18–25] which have been associated with improvements in
sleep architecture [16, 18, 21, 23] and daytime vigilance [23],
though these studies had some methodologic limitations
[13].
In an eﬀort to further deﬁne the role for MMA in OSA,
we sought to review our experience with MMA. In doing
so, we also wanted to address some of the limitations in the
previously performed studies, such as controlling for body
mass index (BMI) pre- and post-MMA and the percent
of time spent supine in the pre- and post-MMA polysom-
nograms, examining changes in the pre- and post-MMA
subjective sleepiness, and presenting tiered AHI outcomes.
In addition, we sought to identify pre-surgical parameters
predictive of surgical success.
2. Methods
After obtaining approval from the Mayo Clinic Institutional
Review Board, we retrospectively reviewed records of con-
secutive patients, 18 years or older, who underwent MMA
for the indication of OSA and had pre- and post-MMA
polysomnograms (PSGs) between November 1, 2004 and
June 30, 2008. Patients with persistent OSA despite previous
surgical interventions as well as surgery na¨ ıve patients
were included. Pre- and post-MMA clinical, demographic,
and PSG data were collected by review of each patient’s
comprehensive electronic medical record.
2.1. Patient Selection. Patients reported herein were accrued
from routine clinical practice and typically had moderate to
severe OSA for which they could not or would not use CPAP.
All underwent a multidisciplinary preoperative evaluation,
including cephalometric radiographs and examinations by
an oral and maxillofacial surgeon (CFV) and an ear, nose,
and throat (ENT) specialist (20 patients; the remaining 4
had either been seen by an ENT specialist elsewhere and
were not deemed a candidate for nasal and/or palatal surgery
or had already undergone nasal and/or palatal surgery),
and a sleep specialist. The ENT exam included ﬂexible
ﬁberoptic nasal endoscopy and laryngoscopy. On the basis
of clinicoradiologic data, patients who eventually underwent
MMA were not felt to have signiﬁcant nasal or palatal
obstruction and were free of signiﬁcant co-morbidities that
might negatively impact surgical risk, such as unstable
cardiopulmonary disease.
2.2. Polysomnography. All patients were evaluated preoper-
atively by a board-certiﬁed/board eligible sleep physician
at our American Academy of Sleep Medicine (AASM)-
accredited sleep facility. All PSG studies were technologist-
attended, in-laboratory examinations using a digital poly-
graph. For the PSGs performed at our facility, the follow-
ing parameters were recorded: electroencephalography (Fz-
Cz,C z-Oz,C 4-M1,o rC 3-M2); electrooculography (right
outer canthus-Fpz; left outer canthus-Fpz); submental and
anterior tibialis electromyography; snoring by laryngeal
microphone; electrocardiography; pulse oximetry; respira-
tory eﬀort (thoracic, abdominal, and summated inductive
plethysmography). Until August 2006, airﬂow was analyzed
by nasal pressure transducer. From September 2006 onward,
airﬂow was analyzed by both oronasal thermal sensor and
nasal pressure transducer. Obstructive apnea was deﬁned as
cessation of airﬂow for at least 10 seconds despite respiratory
eﬀort.Hypopneawasdeﬁnedbya ≥30%reductioninairﬂow
for at least 10 seconds accompanied by at least a 4% drop
in SpO2. Until July 2007, arousals were scored according to
American Sleep Disorders Association criteria [26] and sleep
stages per Rechtschaﬀen and Kales [27]. Thereafter, arousals
and sleep stages were scored per the AASM scoring manual
[28].
Dataonthefollowingpre-andpost-MMAPSGsparame-
ters (when available) were collected: AHI (number of apneas
and hypopneas/hour of sleep); sleep eﬃciency (total sleep
time/time in bed); percentages of nonrapid eye movement
(NREM) and rapid eye movement (REM) sleep; percentage
of time spent in the supine position; initial sleep onset
latency; initial REM latency; lowest oxyhemoglobin sat-
uration (LSAT); mean oxyhemoglobin saturation; arousal
index(numberofarousals/hourofsleep);respiratory-related
arousal index (number of respiratory-related arousals/hour
of sleep). Arousals were deemed respiratory-related if imme-
diately preceded by apneas, hypopneas, periods of at least
10 seconds of diminished airﬂow that did not meet criteria
for hypopnea. Patient sleep position was assessed by the
attending technologist via continuous video monitoring.
2.3.SubjectiveSleepiness. Subjectivesleepinesspre-andpost-
MMA was assessed via the Epworth Sleepiness Scale (ESS)
[29]. Using this questionnaire, patients rate their ease of
falling asleep in 8 potentially sleep-permissive situations
using a 0 (no chance of dozing) to 3 (high chance of dozing)
ranking.Thenumbersforeachscenarioareaddedtoobtaina
total score. Scores of 0–9 are considered normal while scores
of 10–24 imply excessive subjective sleepiness.
2.4. Cephalometric Radiographs and Analysis. Lateral cepha-
lometric radiographs were obtained on each patient preop-
eratively and within 6 months postoperatively. All radio-
graphs were taken by the same technician with patients in
the natural resting head position, not swallowing, and in
complete intercuspation. The phase of respiration was not
controlled during attainment of the lateral cephalometric
radiographs. Pretreatment and posttreatment radiographs
were taken on the same cephalostat by the same operator.
The digital lateral cephalograms were transferred to Dol-
phin imaging and analysis software (Patterson Technology,
Chatsworth, CA). All radiographs were traced by the same
surgeon to ensure proper cephalometric point selection and
eliminate measurement acquisition errors. Linear magniﬁ-
cation of the cephalostat was 10%. Pre- and post-MMA
cephalometrics were digitally superimposed using best ﬁt
of unchanged skull base anatomy to align images in order
to determine millimetric changes in postoperative position
of the following points (Figure 1): anatomic B-point (mostInternational Journal of Otolaryngology 3
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Figure 1: Pre- (a) and post- (b) maxillomandibular advancement (MMA) lateral cephalometric radiographs demonstrating analyzed
parameters. Pre- and post-MMA cephalometric images were digitally overlaid to determine the change in position of the following
parameters:anatomicB-point(mostposteriormidlinepointintheanteriorconcavityofthemandible);posteriornasalspine(PNS)alongthe
sella-nasion line; and sella-nasion-point B (SNB) angle. Enlargement of the posterior airway space was also determined on all cephalometric
radiographs by measuring the narrowest point in the airway pre- and post-MMA, then subtracting the larger (post-MMA) value from the
smaller (pre-MMA) value to obtain the diﬀerence.
posterior midline point in the anterior concavity of the
mandible) to determine mandibular movement and change
in position of the genioglossus muscle; posterior nasal
spine (PNS) along the sella-nasion line to assess maxillary
movement; sella-nasion-point B (SNB) angle to evaluate
change in mandibular position. Enlargement of the posterior
airwaywasalsodeterminedonallcephalometricradiographs
bymanualmeasurementofthenarrowestpoint intheairway
pre- and post-MMA (Figure 1).
2.5. Maxillomandibular Advancement Description. Prior to
the surgical procedures, all patients had intraoperative
surgical guide splints constructed from occlusal models to
allow an accurate advancement of 10mm for the maxilla and
mandible. All surgeries were performed at our institution
by a single surgeon (CFV) under general anesthesia in the
operating room. Hypotensive anesthesia was utilized to min-
imize blood loss. The maxillary osteotomy was performed
ﬁrst and was at the LeFort I level. Minimal mucosal stripping
andpreservationofbloodvesselswasperformedtominimize
risk of devascularization of osseous segments. The maxilla
was advanced 10mm and secured in place with titanium
miniplates and multiple screws. Once this was done, bilateral
mandibular osteotomies were performed using a sagittal
splitting technique to allow the mandible to be advanced.
The mandible was then secured with multiple bicortical
position screws. After conﬁrmation of proper bone position
and occlusal accuracy, the wounds were closed. Patients were
not wired shut; mobility and immediate function (soft diet
limitation) were allowed.
Our patients were all routinely placed in the ICU over-
night to monitor for airway embarrassment due to swelling.
The next morning, they were transferred to a regular room
and allowed to begin oral feeds and oral pain management,
as well as ambulation. None of our patients demonstrated
airway compromise in the perioperative period, nor did
any require reintubation or CPAP/bilevel PAP. Soft diet was
continued for six weeks after discharge from the hospital.
Close followup was completed in all patients (one week,
three weeks, and six weeks after discharge).
2.6. Statistical Analysis. Data were analyzed using JMP soft-
ware (SAS Institute, Cary, NC, USA). Comparisons of con-
tinuous variables were performed using a two-tailed t-test
or Wilcoxon rank-sum test as appropriate, and categorical
responses were compared using chi-square analysis. Paired-
sample t tests were used to compare pre- and postsurgery
data in Table 1. Only data that were available both before and
after MMA were used in the paired analysis. P<0.05 was
considered statistically signiﬁcant. Data are summarized as
mean ± standard deviation.
3. Results
The records of twenty-four OSA patients (18 men [75%])
treatedwithMMAandwithpre-andpostoperativePSGdata
were identiﬁed and analyzed. The mean age at the time of
surgery was 48.3 ±10.8 years. All patients were Caucasians.
Group pre- and post-MMA PSG data are provided in
Table 1. Twelve patients had their pre-MMA PSG elsewhere
and their post-MMA at our facility, while 12 patients
underwent both pre- and post-MMA PSG at our facility.
PSGs were performed 25.9 ± 29.1 months before and 6.7 ±
3.8 months after MMA. The mean absolute decrease in the4 International Journal of Otolaryngology
Table 1: Group pre- and post-maxillomandibular advancement (MMA) demographic- and polysomnographic-matched pair data.
n Pre-MMA
(mean ± SD)
Post MMA
(mean ± SD) P value
ESS 14 13.6 ±5.48 .8 ±3.3 0.0063∗∗
BMI (kg/m2)1 8 3 0 .5 ±6.03 0 .3 ±5.30 . 7
AHI (number/hour) 24 45.4 ±26.47 .8 ±10.5 <0.0001∗∗
Sleep eﬃciency (%) 17 72.2 ±18.97 8 .6 ±16.70 . 2
Stage N1 (%) 15 22.3 ±15.91 4 .2 ±11.20 . 0 8
Stage N2 (%) 15 55.4 ±12.15 5 .3 ±8.30 . 9 7
Stage N3 (%) 15 10.7 ±10.21 5 .3 ±8.30 . 0 4 ∗∗
Stage R (%) 16 9.1 ±7.21 5 .2 ±6.9 0.0078∗∗
Respiratory-related arousals
(events/hour) 12 49.0 ±21.41 1 .5 ±14.9 0.0002∗∗
Lowest oxyhemoglobin
saturation (%) 21 81.2 ±8.08 6 .2 ±5.60 . 0 3 ∗∗
Time in supine position (%) 12 44.4 ±28.54 1 .7 ±28.90 . 7
Abbreviations: SD: standard deviation; ESS: Epworth Sleepiness Scale; BMI: body mass index (kg/m2); AHI: apnea-hypopnea index (apneas and hypopneas
per hour of sleep); N: non-rapid eye movement sleep; R: rapid eye movement sleep.
AHI after MMA was 37.6 ± 5.9events/hour sleep (CI −25.2
to −49.9) (P<0.001) for an average AHI reduction of 83%.
Ten (42%) patients achieved an AHI < 5events/hour sleep;
17 (71%) patients achieved an AHI ≤ 10events/hour sleep;
21(87.5%)patientsachieveda50%AHIreductionand/oran
AHI ≤ 20events/hour sleep. The mean ESS score decreased
by 35% after MMA. The percentages of stages N3 and REM
sleep, the LSAT, and the respiratory-related arousal index
improved during post-MMA PSG. Neither post-MMA BMI
nor the percentage of supine position sleep during the post-
MMA PSG was signiﬁcantly diﬀerent from pre-MMA values.
Table 2 provides patient-speciﬁc data on pre-MMA
upper airway surgeries, maxillary and mandibular advance-
ment, and changes in AHI. Eight (30%) patients had previ-
ous upper airway surgeries.
All but one patient enjoyed an AHI reduction. This
patient was a 61-year-old man with OSA and multifactorial
insomnia. His BMI was normal (24kg/m2), and his orophar-
ynx conﬁguration was Grade II per modiﬁed Mallampati
technique [30]. The preoperative AHI was 26events/hour
sleep; the postoperative AHI was 42events/hour sleep. The
outcome could not be explained by diﬀerences in weight,
the frequency of central apneas, or the amount of supine
position sleep during PSG. He eventually underwent hyoid
suspension at another institution with a resultant drop in his
AHI to 15events/hour sleep. This patient had a presurgical
ClassIIImalocclusion (underbite)andhadbeentreatedwith
orthodontics elsewhere prior to presenting to us for surgery.
Surgical correction of the class III malocclusion resulted in
less anterior movement of the mandible than is typical in
MMA surgery. The mandibular advancement was only 3
millimeters. This lesser movement most likely was the cause
of the poor response to MMA in this isolated patient.
Comparing various parameters between those cured of
O S Ab yM M A( d e ﬁ n e db yp o s t o p e r a t i v eA H I< 5events/
hour sleep) versus those with residual sleep disordered
breathing, no signiﬁcant diﬀerences were found with respect
toage,gender,pre-orpostoperativeBMI,priorupperairway
surgery, amount of maxillomandibular advancement, or
cephalometric measurements (Table 3).
4. Discussion
This study adds to the literature that MMA results in a sub-
stantial reduction of the AHI in the majority of nonrandom-
izedpatientsdescribedincaseseries.Inourstudypopulation
of patients with generallysevere OSA,there wasan 83% drop
in the mean AHI, a value congruent with the 87% reduction
by MMA per a recent review of upper airway surgeries for
OSA sponsored by the AASM [31] and the 85% reduction
reported in an MMA meta-analysis by Holty and Guillem-
inault [32]. The latter publication also reported an average
residual AHI of 9.5±10.7events/hour sleep, which compares
to an average residual AHI of 7.8events ±10.5events/hour
sleep in our group with equally severe OSA.
There has been a call [13]f o ru s eo fm o r es t r i n g e n t
criteria (i.e., postsurgical AHI < 5events/hour sleep) for
judging success of surgical treatment for OSA beyond the
traditional deﬁnition of at least a 50% reduction in AHI and
residual AHI < 20events/hour sleep. With this in mind, we
herein report our AHI outcomes in a tiered manner with 10
(42%) patients achieving a post-MMA AHI < 5events/hour
sleep and 17 (71%) patients reaching a post-MMA AHI <
10events/hoursleep.Similarly,HoltyandGuilleminault[32]
reported that 43% and 63% of patients in their meta-analysis
had AHI < 5 and AHI < 10, respectively, after MMA.
TheMMAmeta-analysis[32]foundthatyoungerpatient
age, lower preoperative weight, lower preoperative AHI, and
greater degree of maxillary advancement were predictive
of increased MMA success. We did not ﬁnd any variables
that were predictive of success in our group. There were
no signiﬁcant diﬀerences in age, gender, BMI, preoperative
AHI, amount of advancement of the jaws, or cephalometric
parameters. We suspect that our inability to detect criticalInternational Journal of Otolaryngology 5
Table 2: Selected, patient-speciﬁc data on demographics, previous airway surgery, surgical advancement, and sleep-disordered breathing
pre- and post-maxillomandibular advancement (MMA).
Patient Gender Pre-MMA upper
airway surgery Age at MMA
Maxillary
advancement
(mm)
Mandibular
advancement
(mm)
Pre-MMA
AHI
Post-MMA
AHI
%A H I
reduction
1 F None 39 8 7 24 1 96
2 M None 45 NA NA 30 1 97
3 F None 57 9 9 21 11 48
4M UPPP, bilateral
tonsillectomy 48 8 8 37 11 70
5 M None 61 10 3 26 42 —
6 M UPPP 36 10 10 80 1 99
7 M None 35 6 6 23 1 96
8M
UPPP,
Genioglossus
advancement
33 10 10 38 0 100
9 F None 55 10 10 80 11 86
10 M UPPP, nasal
septoplasty 54 10 10 37 1 97
1 1 MN o n e5 5 7781 8 8
1 2 M N o n e 4 21 01 01 2 5 5 8
1 3 M N o n e 5 78 85 45 9 1
1 4 M N o n e 4 91 01 05 2 2 9 6
15 F UPPP, nasal
septoplasty 48 10 10 56 1 98
1 6 M N o n e 5 61 01 03 7 9 7 6
1 7 M N o n e 4 51 01 02 5 5 8 0
18 M UPPP 44 12 12 117 1 99
19 M None 26 NA NA 33 11 67
20 M UPPP, nasal
septoplasty 50 10 10 39 7 82
21 F None 71 NA NA 53 14 74
2 2 M N o n e 3 01 01 09 5 6 9 4
2 3 F N o n e 5 81 01 05 13 6 2 9
24 M Genial
advancement 51 10 10 60 5 92
Abbreviations: F: female; M: male; UPPP: uvulopalatopharyngoplasty; AHI: apnea-hypopnea index (apneas and hypopneas/hour sleep); NA: data not
available.
clinical, surgical, and cephalometric thresholds for success
was due to our limited population size.
Determining the role for any upper airway surgery in the
management of OSA has been complicated by methodologic
limitations in the surgical literature, including irregularities
in the performance and interpretation of PSG (such as
controlling for the percent sleep time in the more vulnerable
supine position), lack of secondary outcome data beyond
AHI (such as sleep architecture and ESS), and failure to
control for the potential confounding of peri-procedural
changes in BMI [12, 13]. This study attempted to address
theseissueswhenpossible.Thepercentageofsupineposition
sleep was controlled for when comparing the pre- and post-
MMA AHI results, the ﬁrst such time that we know of in
the MMA literature. As there were no signiﬁcant diﬀerences,
ourMMAresultswerenot positively inﬂuenced bydecreased
supine sleep on the postoperative PSG. Pertaining to out-
comes of MMA beyond impact on the AHI, our report adds
to the much smaller body evidence on post-MMA sleep
architectureandsubjectivesleepiness(sleeparchitecturedata
were available in only 46% of patients in the Holty and
Guilleminault’s meta-analysis [32]o f6 2 7p a t i e n t sa n dE S S
data in just 7%). Our sleep architecture improvements mir-
ror those reported by others [16, 18, 21, 23], while the pre-
and post-MMA ESS improvement data are also similar. The
groupmeanESSscoredropby5inourseriesisareductionat
l e a s ta ss t r o n ga sr e p o r t e dw i t hC P A Pi np a t i e n t sw i t hs e v e r e
OSA [33]. BMI was accounted for pre- and post-MMA and
did not change signiﬁcantly suggesting that success of MMA
could not simply be attributed to weight loss after surgery.
Thisstudysharesanumberoflimitationscommoninthe
OSA surgical literature. Our patients were not randomized6 International Journal of Otolaryngology
Table 3: Comparison of parameters between patients cured versus those with residual obstructive sleep apnea following maxillomandibular
advancement (MMA).
Post-MMA
Surgical cure (AHI < 5)
N = 10; 42%
(mean ± SD)
n
No cure (AHI ≥ 5)
N = 14; 58%
(mean ± SD)
nP value
Pre-MMA 14
Age (years) 44.4 ±7.81 0 5 1 .0 ±12.01 4 0 . 0 7
Male (%) 80 8 71.4 10 0.5
BMI 30.3 ±4.49 3 1 .0 ±6.51 2 0 . 9
AHI (events/h) 46.5 ±31.91 0 4 4 .6 ±23.01 4 0 . 9
SpO2 nadir (%) 81.1 ±9.61 0 8 1 .3 ±6.61 2 0 . 7
Previous phase-I surgery1 (%) 62.5 5/8 37.5 3/8 0.2
Surgery
Maxillary advancement (mm) 9.2 ±1.99 9 .6 ±0.81 2 0 . 8
Mandibular advancement (mm) 9.1 ±2.09 9 .0 ±2.01 2 0 . 9
Post-MMA
BMI (kg/m2)2 9 .2 ±7.18 3 0 .0 ±3.81 3 0 . 9
% Change in BMI (%) −1.7 ±5.570 .5 ±6.71 1 0 . 6
AHI (events/h) 1.0 ±0.51 0 1 2 .7 ±11.61 4 <0.0001
% Change in AHI (%) −96.5 ±3.51 0 −63.2 ±40.11 4 <0.0001
SpO2 nadir (%) 88.8 ±4.21 0 8 4 .1 ±5.2 14 0.0221
% Change in SpO2 nadir (%) 10.9 ±14.91 0 3 .9 ±12.81 2 0 . 2
Abbreviations: SD: standard deviation; BMI: body mass index (kg/m2); AHI: apnea-hypopnea index (apneas and hypopneas/hour sleep); SpO2: oxyhe-
moglobin saturation.
1Patients who underwent an upper airway procedure prior to MMA.
to MMA, although there are signiﬁcant practical hurdles to
randomization in surgical trials for OSA, especially with an
invasive surgery with cosmetic ramiﬁcations such as MMA.
Not all patients who underwent MMA at our institution
during the data collection period underwent postprocedural
PSG. We did not have pre- and post-MMA matched data
for every parameter for every patient either because the pre-
MMA PSG was performed elsewhere or the documentation
wasincomplete,aprobleminherentinretrospectiveanalyses.
In the case of patients who had their pre-MMA PSG at
another institution, a repeat pre-operative study was not
performed because it was either deemed clinically unnec-
essary or logistically impractical. Systematic documentation
of post-MMA complications was not performed so adverse
outcomes are not reported herein.
Our study population included 8 patients who had pre-
viously undergone surgeries for OSA, mostly UPPP, which
limits our ability to discern the speciﬁc impact of MMA.
The patient numbers were too small to determine the impact
of the speciﬁc previous upper airway surgeries on response
to MMA. However, the frequency of previous surgery likely
reﬂects, at least in part, the enduring paradigm of a step-
wise surgical approach to OSA in which site-speciﬁc phase
I surgery addresses areas deemed susceptible to obstruction
in the naso-, oro-, or hypopharyngeal regions, while phase II
surgery consists of facial skeletal advancement (i.e., MMA)
for residual disease [34]. Debate continues about how best to
determine a successful outcome from OSA treatment. Using
the admittedly narrow but important endpoint of impact on
AHI, the pooled success rate for phase I surgeries achieving
an AHI ≤ 10events/hour sleep is 31%, and an AHI of
≤5events/hour sleep is 13% [13]. Considering that the
impact of MMA on AHI is more substantial, the results
have been replicated at multiple institutions and that the
AHI response appears durable for at least at 2 years [18], an
argument can be made for proceeding directly to MMA in
patients seeking a surgical approach to their OSA.
5. Conclusion
CPAP remains the standard treatment for most patients with
OSA [5]. However, MMA provides an alternative for OSA
patients who cannot or will not use CPAP. Experience is
growing with this procedure which yields a signiﬁcant drop
in AHI and is associated with improvements in sleep archi-
tecture and subjective sleepiness.
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